trending Market Intelligence /marketintelligence/en/news-insights/trending/qsHBV4sl1op9sdt0MGfS-Q2 content esgSubNav
In This List

Xenetic appoints 3 directors

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Xenetic appoints 3 directors

Adam Logal, James Callaway and Dmitry Genkin joined Xenetic Biosciences Inc.'s board.

Logal is the senior vice president, CFO, chief accounting officer and treasurer of Opko Health Inc. Callaway serves as a corporate strategy consultant at Callaway Innovations.

Genkin is chairman of PJSC Pharmsynthez and previously served on the company's board from 2004 to 2016.